Correlation Between Novartis and Horizon Pharma
Can any of the company-specific risk be diversified away by investing in both Novartis and Horizon Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Horizon Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG and Horizon Pharma PLC, you can compare the effects of market volatilities on Novartis and Horizon Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Horizon Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Horizon Pharma.
Diversification Opportunities for Novartis and Horizon Pharma
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Novartis and Horizon is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Horizon Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Horizon Pharma PLC and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Horizon Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Horizon Pharma PLC has no effect on the direction of Novartis i.e., Novartis and Horizon Pharma go up and down completely randomly.
Pair Corralation between Novartis and Horizon Pharma
If you would invest 9,092 in Novartis AG on August 25, 2024 and sell it today you would earn a total of 1,308 from holding Novartis AG or generate 14.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 0.4% |
Values | Daily Returns |
Novartis AG vs. Horizon Pharma PLC
Performance |
Timeline |
Novartis AG |
Horizon Pharma PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Novartis and Horizon Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novartis and Horizon Pharma
The main advantage of trading using opposite Novartis and Horizon Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Horizon Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Horizon Pharma will offset losses from the drop in Horizon Pharma's long position.Novartis vs. Roche Holding AG | Novartis vs. AstraZeneca PLC | Novartis vs. Roche Holding Ltd | Novartis vs. Sanofi ADR |
Horizon Pharma vs. Bristol Myers Squibb | Horizon Pharma vs. AbbVie Inc | Horizon Pharma vs. Merck Company | Horizon Pharma vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |